Fmoc-L-3-amino-4,4-diphenylbutyric acid is a non-natural, sterically hindered amino acid derivative. Its structure features a diphenylmethyl group at the beta-position relative to the carboxylic acid, and the alpha-amino group is protected with a 9-fluorenylmethoxycarbonyl (Fmoc) group, which is standard for solid-phase peptide synthesis (SPPS). This compound is primarily used as a specialized building block in peptide chemistry and medicinal chemistry research. The bulky, hydrophobic diphenyl side chain is incorporated into peptide sequences to induce specific conformational constraints, enhance metabolic stability, or modulate the peptide's interaction with biological targets. It is particularly valuable for designing peptidomimetics and investigating structure-activity relationships (SAR) in drug discovery programs targeting protein-protein interactions. As an Fmoc-protected amino acid, it is directly compatible with standard Fmoc-SPPS protocols. Its synthesis and application are documented in scientific literature focused on developing novel bioactive peptides and constrained analogs.